News

Healio21h
FDA approves Moderna COVID-19 vaccine for some children
The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...
Moderna gets full FDA approval for kids COVID-19 vaccine
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
Pharmabiz12h
US FDA approves Moderna’s Covid-19 vaccine, Spikevax in children aged 6 months through 11 years at increased risk for Covid-19 disease
US FDA approves Moderna’s Covid-19 vaccine, Spikevax in children aged 6 months through 11 years at increased risk for Covid-19 disease: Cambridge, Massachusetts Saturday, July 1 ...
American Hospital Association23h
COVID-19 vaccination approved for older adults and high-risk, younger children
The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...
Zacks Investment Research on MSN19h
Moderna (MRNA) Suffers a Larger Drop Than the General Market: Key Insights
In the latest close session, Moderna (MRNA) was down 1.87% at $33.64. This move lagged the S&P 500's daily loss of 0.33%. Meanwhile, the Dow lost 0.63%, and the Nasdaq, a tech-heavy index, lost 0.22%.
Gulf Times23h
Qatar study highlights role of post-vaccination monitoring
A Qatar-based study involving 121,700 patients has underscored the importance of the post-vaccination monitoring to optimise ...
Explore more
StockStory.org on MSN22h
U.S. Physical Therapy, Evolent Health, Charles River Laboratories, Moderna, and Intuitive Surgical Shares Are Falling, What You Need To Know
What Happened? A number of stocks fell in the morning session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market ...